Please try another search
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease (CAD) rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden.
Name | Age | Since | Title |
---|---|---|---|
Louise Marie Janssen-Counotte | 59 | 2020 | Independent Director |
Fredrik Buch | 70 | 2021 | Independent Director |
Ulf Rosén | 64 | 2014 | Independent Director |
Deepak R. Talreja | - | 2023 | Medical Advisor |
Philip Siberg | 51 | 2021 | Independent Chairman of the Board |
Mikael Thorén | 60 | 2023 | Independent Director |
Peter Clemmensen | - | - | Member of Clinical Advisory Board |
Dave Braun | - | 2024 | Member of the Advisory Board |
Kenneth Nelson | 48 | 2024 | Director & Member of the Advisory Board |
Tony Das | - | 2024 | Director |
Morten Bottcher | - | - | Member of Clinical Advisory Board |
David Erlinge | - | - | Member of Clinical Advisory Board |
John Cleland | - | - | Member of Clinical Advisory Board |
Saumil R. Oza | - | 2024 | Member of the Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review